Leading Minds Network to Convene Biopharma and Logistics Leaders in San Diego for Cold Chain Seminar

The Leading Minds Network, powered by ELPRO and Cold Chain Technologies, will host its upcoming “From Lab to Launch: De-Risking the Biologic Cold Chain” seminar in San Diego, bringing together top experts across the pharmaceutical, biotech, life science, healthcare, and logistics sectors for a collaborative, in‑depth learning experience.

Taking place June 8–10, 2026, the exclusive event is designed to address the rapidly evolving challenges of biologics distribution and temperature-sensitive supply chains. The seminar will combine expert-led sessions, interactive panels, and networking opportunities in a retreat-style setting to foster open dialogue and practical knowledge exchange.

The program will feature industry-leading speakers from organizations including Eli Lilly, Moderna, McKesson, Vertex Pharmaceuticals, Cardinal Health, and DSV, among others. Attendees will engage in discussions on critical topics such as real-time logistics control, radiopharmaceutical supply challenges, FDA expectations in 2026, direct-to-patient delivery models, and advancements in ultra-cold and cryogenic transport.

“The complexity of biologic and advanced therapy supply chains continues to rise, making collaboration across the industry more important than ever,” says Leading Minds Network Director Martin Davis. “This seminar is designed to bring together diverse expertise from across pharma, life science and logistics to share real-world insights, risk reduction strategies, and ultimately improve patient outcomes,” notes Davis.

The multi-day event will begin with a networking reception on June 8, followed by a full day of sessions and panels on June 9, and conclude with an exclusive tour of the Cold Chain Technologies hub on June 10.

Past attendees of Leading Minds Network events include professionals from leading global organizations such as Amgen, AbbVie, Biogen, Pfizer, Vertex Pharmaceuticals, Eli Lilly, Moderna, Johnson & Johnson, Novo Nordisk, AstraZeneca, GSK, Bristol-Myers Squibb, Bayer, Merck/MSD, Sanofi and Boehringer Ingelheim, underscoring the significance and industry reach of the series.

About Leading Minds Network

Powered by ELPRO and Cold Chain Technologies, Leading Minds Network is a collaborative learning community that brings together global industry leaders to share ideas, challenges and best practices to ultimately fulfill a shared mission: to provide safe and effective medications and therapies to patients. The initiative is further strengthened by Cold Chain Platform as its media partner and ASC Associates as an associate partner, helping to expand industry reach and deepen engagement.

For more information visit: https://www.leading-minds-network.com

Source: Leading Minds Network